Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct.

Luvira V, Kamsa-Ard S, Pugkhem A, Luvira V, Srisuk T, Titapun A, Silsirivanit A, Wongkham S, Khuntikeo N, Pairojkul C, Bhudhisawasdi V.

Clin Exp Hepatol. 2019 Sep;5(3):250-255. doi: 10.5114/ceh.2019.87641. Epub 2019 Sep 5.

2.

Bayesian spatial analysis of cholangiocarcinoma in Northeast Thailand.

Suwannatrai AT, Thinkhamrop K, Clements ACA, Kelly M, Suwannatrai K, Thinkhamrop B, Khuntikeo N, Gray DJ, Wangdi K.

Sci Rep. 2019 Oct 3;9(1):14263. doi: 10.1038/s41598-019-50476-7.

3.

Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.

Jamnongkan W, Lebrilla CB, Barboza M, Techasen A, Loilome W, Sithithaworn P, Khuntikeo N, Pairojkul C, Chamadol N, Thanan R, Yongvanit P.

Biomolecules. 2019 Sep 27;9(10). pii: E538. doi: 10.3390/biom9100538.

4.

In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues.

Suksawat M, Klanrit P, Phetcharaburanin J, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Sa-Ngiamwibool P, Techasen A, Loilome W.

PLoS One. 2019 Sep 10;14(9):e0222140. doi: 10.1371/journal.pone.0222140. eCollection 2019.

5.

Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.

Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W.

PLoS One. 2019 Aug 19;14(8):e0221024. doi: 10.1371/journal.pone.0221024. eCollection 2019.

6.

Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis.

Duangkumpha K, Stoll T, Phetcharaburanin J, Yongvanit P, Thanan R, Techasen A, Namwat N, Khuntikeo N, Chamadol N, Roytrakul S, Mulvenna J, Mohamed A, Shah AK, Hill MM, Loilome W.

J Proteome Res. 2019 Sep 6;18(9):3305-3316. doi: 10.1021/acs.jproteome.9b00242. Epub 2019 Jul 31.

PMID:
31310545
7.

Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.

Chaiprasert T, Armartmuntree N, Techasen A, Sakonsinsiri C, Pinlaor S, Ungarreevittaya P, Khuntikeo N, Namwat N, Thanan R.

Biomolecules. 2019 Jul 7;9(7). pii: E263. doi: 10.3390/biom9070263.

8.

Frailty Syndrome in Biliary Tract Cancer Patients: Prevalence and Associated Factors

Limpawattana P, Wirasorn K, Sookprasert A, Sawanyawisuth K, Titapun A, Luvira V, Khuntikeo N, Chindaprasirt J.

Asian Pac J Cancer Prev. 2019 May 25;20(5):1497-1501.

9.

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.

Vaeteewoottacharn K, Pairojkul C, Kariya R, Muisuk K, Imtawil K, Chamgramol Y, Bhudhisawasdi V, Khuntikeo N, Pugkhem A, Saeseow OT, Silsirivanit A, Wongkham C, Wongkham S, Okada S.

Cells. 2019 May 23;8(5). pii: E496. doi: 10.3390/cells8050496.

10.

Correction to: Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.

Thinkhamrop K, Khuntikeo N, Sithithaworn P, Thinkhamrop W, Wangdi K, Kelly MJ, Suwannatrai AT, Gray DJ.

Infect Dis Poverty. 2019 May 16;8(1):33. doi: 10.1186/s40249-019-0546-4.

11.

Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.

Chamadol N, Khuntikeo N, Thinkhamrop B, Thinkhamrop K, Suwannatrai AT, Kelly M, Promthet S.

BMJ Open. 2019 Mar 20;9(3):e023217. doi: 10.1136/bmjopen-2018-023217. Erratum in: BMJ Open. 2019 May 30;9(5):e023217corr1.

12.

Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand.

Thinkhamrop K, Khuntikeo N, Sithithaworn P, Thinkhamrop W, Wangdi K, Kelly MJ, Suwannatrai AT, Gray DJ.

Infect Dis Poverty. 2019 Mar 20;8(1):18. doi: 10.1186/s40249-019-0529-5. Erratum in: Infect Dis Poverty. 2019 May 16;8(1):33.

13.

Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand.

Worasith C, Wangboon C, Duenngai K, Kiatsopit N, Kopolrat K, Techasen A, Sithithaworn J, Khuntikeo N, Loilome W, Namwat N, Yongvanit P, Carlton EJ, Sithithaworn P.

PLoS Negl Trop Dis. 2019 Feb 8;13(2):e0007186. doi: 10.1371/journal.pntd.0007186. eCollection 2019 Feb.

14.

Cholangiocarcinoma: a guide for the nonspecialist.

Alsaleh M, Leftley Z, Barbera TA, Sithithaworn P, Khuntikeo N, Loilome W, Yongvanit P, Cox IJ, Chamodol N, Syms RR, Andrews RH, Taylor-Robinson SD.

Int J Gen Med. 2018 Dec 20;12:13-23. doi: 10.2147/IJGM.S186854. eCollection 2019. Review.

15.

The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis.

Khuntikeo N, Thinkhamrop B, Bundhamcharoen K, Andrews RH, Grundy-Warr C, Yongvanit P, Loilome W, Chamadol N, Kosuwan W, Sithithaworn P, Petney TN.

Adv Parasitol. 2018;102:141-163. doi: 10.1016/bs.apar.2018.06.003. Epub 2018 Jul 18.

PMID:
30442308
16.

Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.

Wangboon C, Worasith C, Thanan R, Eamudomkarn C, Techasen A, Sithithaworn J, Loilome W, Chamadol N, Pinlaor S, Jumnainsong A, Yongvanit P, Khuntikeo N, Bethony JM, Sithithaworn P.

Acta Trop. 2019 Jan;189:124-128. doi: 10.1016/j.actatropica.2018.10.003. Epub 2018 Oct 12.

PMID:
30321522
17.

The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients.

Limpawattana P, Theerakulpisut D, Wirasorn K, Sookprasert A, Khuntikeo N, Chindaprasirt J.

PLoS One. 2018 Oct 10;13(10):e0204985. doi: 10.1371/journal.pone.0204985. eCollection 2018.

18.

The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma.

Kaewlert W, Sakonsinsiri C, Namwat N, Sawanyawisuth K, Ungarreevittaya P, Khuntikeo N, Armartmuntree N, Thanan R.

Horm Cancer. 2018 Dec;9(6):408-419. doi: 10.1007/s12672-018-0349-2. Epub 2018 Oct 3.

PMID:
30284180
19.

Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth.

Padthaisong S, Dokduang H, Yothaisong S, Techasen A, Namwat N, Yongvanit P, Khuntikeo N, Titapun A, Sangkhamanon S, Loilome W.

Oncol Lett. 2018 Aug;16(2):1627-1633. doi: 10.3892/ol.2018.8848. Epub 2018 May 31.

20.

Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.

Silakit R, Kitirat Y, Thongchot S, Loilome W, Techasen A, Ungarreevittaya P, Khuntikeo N, Yongvanit P, Yang JH, Kim NH, Yook JI, Namwat N.

PLoS One. 2018 Jun 28;13(6):e0199827. doi: 10.1371/journal.pone.0199827. eCollection 2018.

21.

Analysis of a school-based health education model to prevent opisthorchiasis and cholangiocarcinoma in primary school children in northeast Thailand.

Laithavewat L, Grundy-Warr C, Khuntikeo N, Andrews RH, Petney TN, Yongvanit P, Banchonhattakit P, Sithithaworn P.

Glob Health Promot. 2018 May 1:1757975918767622. doi: 10.1177/1757975918767622. [Epub ahead of print]

PMID:
29809091
22.

Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia.

Khuntikeo N, Titapun A, Loilome W, Yongvanit P, Thinkhamrop B, Chamadol N, Boonmars T, Nethanomsak T, Andrews RH, Petney TN, Sithithaworn P.

Front Med (Lausanne). 2018 Apr 30;5:117. doi: 10.3389/fmed.2018.00117. eCollection 2018. Review.

23.

Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.

Wangboon C, Yongvanit P, Loilome W, Thanan R, Worasith C, Eamudomkarn C, Chamadol N, Mairiang E, Sithithaworn J, Saichua P, Sripa B, Khuntikeo N, Bethony JM, Sithithaworn P.

Am J Trop Med Hyg. 2018 Jun;98(6):1763-1769. doi: 10.4269/ajtmh.17-0971. Epub 2018 Apr 5.

24.

Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.

Onsurathum S, Haonon O, Pinlaor P, Pairojkul C, Khuntikeo N, Thanan R, Roytrakul S, Pinlaor S.

Tumour Biol. 2018 Apr;40(4):1010428318767195. doi: 10.1177/1010428318767195.

PMID:
29629840
25.

Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine.

Kittirat Y, Techasen A, Thongchot S, Loilome W, Thanan R, Yongvanit P, Sungkhamanon S, Titapun A, Khuntikeo N, Namwat N.

Oncol Lett. 2018 Jan;15(1):347-353. doi: 10.3892/ol.2017.7326. Epub 2017 Nov 1.

26.

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.

Utaijaratrasmi P, Vaeteewoottacharn K, Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N, Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, Thuwajit P, Thuwajit C, Kudo Y.

Mol Cancer. 2018 Jan 18;17(1):10. doi: 10.1186/s12943-018-0760-x.

27.

Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma.

Chamadol N, Laopaiboon V, Srinakarin J, Loilome W, Yongvanit P, Thinkhamrop B, Khuntikeo N.

ESMO Open. 2017 Aug 22;2(3):e000231. doi: 10.1136/esmoopen-2017-000231. eCollection 2017.

28.

Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study.

Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS.

Version 2. F1000Res. 2017 Sep 4 [revised 2017 Jan 1];6:1630. doi: 10.12688/f1000research.12417.2. eCollection 2017.

29.

Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis.

Phanthaphol N, Techasen A, Loilome W, Thongchot S, Thanan R, Sungkhamanon S, Khuntikeo N, Yongvanit P, Namwat N.

Oncol Lett. 2017 Nov;14(5):5973-5979. doi: 10.3892/ol.2017.6985. Epub 2017 Sep 18.

30.

Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand.

Songthamwat M, Chamadol N, Khuntikeo N, Thinkhamrop J, Koonmee S, Chaichaya N, Bethony J, Thinkhamrop B.

World J Surg Oncol. 2017 Sep 20;15(1):176. doi: 10.1186/s12957-017-1246-9.

31.

Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem.

Hughes T, O'Connor T, Techasen A, Namwat N, Loilome W, Andrews RH, Khuntikeo N, Yongvanit P, Sithithaworn P, Taylor-Robinson SD.

Int J Gen Med. 2017 Aug 10;10:227-237. doi: 10.2147/IJGM.S133292. eCollection 2017. Review.

32.

Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.

Surapaitoon A, Suttiprapa S, Mairiang E, Khuntikeo N, Pairojkul C, Bethony J, Brindley PJ, Sripa B.

Korean J Parasitol. 2017 Jun;55(3):295-304. doi: 10.3347/kjp.2017.55.3.295. Epub 2017 Jun 30.

33.

Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish

Sripan P, Boonmars T, Songsri J, Aukkanimart R, Sriraj P, Rattanasuwan P, Boueroy P, Suwannatrai A, Aunpromma S, Khuntikeo N, Loilome W, Namwat N, Yongvanit P, PhyoWai A, Khueangchaingkhwang S, Zhilang W, Pumhirunroj B, Artchayasawat A, Boonjaraspinyo S.

Asian Pac J Cancer Prev. 2017 Jun 25;18(6):1507-1511.

34.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

35.

Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma.

Loilome W, Kadsanit S, Muisook K, Yongvanit P, Namwat N, Techasen A, Puapairoj A, Khuntikeo N, Phonjit P.

Oncol Lett. 2017 Feb;13(2):639-646. doi: 10.3892/ol.2016.5477. Epub 2016 Dec 8.

36.

Carcinogenic Liver Fluke and Others Contaminated in Pickled Fish of Northeastern Thailand

Aukkanimart R, Boonmars T, Sriraj P, Sripan P, Songsri J, Ratanasuwan P, Laummaunwai P, Suwanantrai A, Aunpromma S, Khueangchaingkhwang S, Pumhirunroj B, Artchayasawat A, Khuntikeo N, Loilome W, Namwat N, Yongvanit P, Boonjaraspinyo S.

Asian Pac J Cancer Prev. 2017 Feb 1;18(2):529-533.

37.

Genetic characterization of Helicobacter pylori vacA and cagA genes in Thai gastro-duodenal and hepatobiliary patients.

Boonyanugomol W, Khuntikeo N, Pugkhem A, Sawadpanich K, Hahnvajanawong C, Wongphutorn P, Khampoosa B, Chomvarin C.

J Infect Dev Ctries. 2017 Jan 30;11(1):42-50. doi: 10.3855/jidc.8126.

38.

Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.

Rucksaken R, Charoensuk L, Pinlaor P, Pairojkul C, Khuntikeo N, Pinlaor S.

Cancer Biomark. 2017;18(1):27-34. doi: 10.3233/CBM-160670.

PMID:
27814272
39.

Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients.

Surapaitoon A, Suttiprapa S, Khuntikeo N, Pairojkul C, Sripa B.

Parasitol Int. 2017 Feb;66(1):889-892. doi: 10.1016/j.parint.2016.10.009. Epub 2016 Oct 18.

40.

Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand.

Khuntikeo N, Sithithaworn P, Loilom W, Namwat N, Yongvanit P, Thinkhamrop B, Kiatsopit N, Andrews RH, Petney TN.

Acta Trop. 2016 Dec;164:469-472. doi: 10.1016/j.actatropica.2016.10.017. Epub 2016 Oct 26.

PMID:
27794488
41.

Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma.

Dai X, Thongchot S, Dokduang H, Loilome W, Khuntikeo N, Titapun A, Ungarreevittaya P, Yongvanit P, Techasen A, Namwat N.

Anticancer Res. 2016 Nov;36(11):5981-5988.

PMID:
27793924
42.

Factors Associated with Periductal Fibrosis Diagnosed by Ultrasonography Screening among a High Risk Population for Cholangiocarcinoma in Northeast Thailand.

Intajarurnsan S, Khuntikeo N, Chamadol N, Thinkhamrop B, Promthet S.

Asian Pac J Cancer Prev. 2016;17(8):4131-6.

43.

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.

Chng KR, Chan SH, Ng AHQ, Li C, Jusakul A, Bertrand D, Wilm A, Choo SP, Tan DMY, Lim KH, Soetinko R, Ong CK, Duda DG, Dima S, Popescu I, Wongkham C, Feng Z, Yeoh KG, Teh BT, Yongvanit P, Wongkham S, Bhudhisawasdi V, Khuntikeo N, Tan P, Pairojkul C, Ngeow J, Nagarajan N.

EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034. Epub 2016 May 6.

44.

CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.

Thanee M, Loilome W, Techasen A, Sugihara E, Okazaki S, Abe S, Ueda S, Masuko T, Namwat N, Khuntikeo N, Titapun A, Pairojkul C, Saya H, Yongvanit P.

Cancer Sci. 2016 Jul;107(7):991-1000. doi: 10.1111/cas.12967. Epub 2016 Jun 20.

45.

Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance.

Suksawat M, Techasen A, Namwat N, Yongvanit P, Khuntikeo N, Titapun A, Koonmee S, Loilome W.

Parasitol Int. 2017 Aug;66(4):486-493. doi: 10.1016/j.parint.2016.04.008. Epub 2016 Apr 30.

PMID:
27143607
46.

Untangling the Complexity of Liver Fluke Infection and Cholangiocarcinoma in NE Thailand Through Transdisciplinary Learning.

Ziegler AD, Echaubard P, Lee YT, Chuah CJ, Wilcox BA, Grundy-Warr C, Sithithaworn P, Petney TN, Laithevewat L, Ong X, Andrews RH, Ismail T, Sripa B, Khuntikeo N, Poonpon K, Tungtang P, Tuamsuk K.

Ecohealth. 2016 Jun;13(2):316-27. doi: 10.1007/s10393-015-1087-3. Epub 2016 Jan 28.

PMID:
26822781
47.

A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.

Khuntikeo N, Loilome W, Thinkhamrop B, Chamadol N, Yongvanit P.

PLoS Negl Trop Dis. 2016 Jan 21;10(1):e0004293. doi: 10.1371/journal.pntd.0004293. eCollection 2016 Jan. No abstract available.

48.

Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice.

Kongpetch S, Puapairoj A, Ong CK, Senggunprai L, Prawan A, Kukongviriyapan U, Chan-On W, Siew EY, Khuntikeo N, Teh BT, Kukongviriyapan V.

Cell Prolif. 2016 Feb;49(1):90-101. doi: 10.1111/cpr.12228. Epub 2016 Jan 4.

PMID:
26726846
49.

Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand.

Titapun A, Pugkhem A, Luvira V, Srisuk T, Somintara O, Saeseow OT, Sripanuskul A, Nimboriboonporn A, Thinkhamrop B, Khuntikeo N.

World J Gastrointest Oncol. 2015 Dec 15;7(12):503-12. doi: 10.4251/wjgo.v7.i12.503.

50.

Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.

Yothaisong S, Namwat N, Yongvanit P, Khuntikeo N, Puapairoj A, Jutabha P, Anzai N, Tassaneeyakul W, Tangsucharit P, Loilome W.

Parasitol Int. 2017 Aug;66(4):471-478. doi: 10.1016/j.parint.2015.11.011. Epub 2015 Nov 30.

PMID:
26657242

Supplemental Content

Loading ...
Support Center